Numerous proteins are involved in the progression of cancer where protein kinase CK2α and tankyrases (tankyrase1 and tankyrase2) were reported earlier as potential molecular targets to treat various human pathophysiological disorders and found to be overexpressed in several cancer cells [3,4]. This evidence concerns the gene TNKS and cancer.